Literature DB >> 29736317

KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression.

Mandayam O Nandan1, Agnieszka B Bialkowska1, Vincent W Yang1,2.   

Abstract

Oncogenic K-Ras activation is a common mutational event in colorectal cancer. We previously showed that transcription factor, Krüppel-like factor 5 (KLF5), contributes to intestinal polyposis in mice with K-Ras activation. At 14 months of age, Villin-Cre/LSL-K-RasG12D mice developed small intestinal and colonic hyperplastic polyps while LSL-K-RasG12D had none. The intestinal crypts of Villin-Cre/LSL-K-RasG12D mice contained a higher number of mitotic figures and increased crypt heights compared to controls. The intestinal epithelium of Villin-Cre/LSL-K-RasG12D mice showed prolific KLF5 expression throughout and above the elongated crypts. In contrast, KLF5 expression was limited to the upper crypt region in the controls. The levels of K-Ras effectors were significantly increased in Villin-Cre/LSL-K-RasG12D as compared to controls. The Villin-Cre/LSL-K-RasG12D mice showed decreased survival upon treatment with azoxymethane (AOM) as compared to controls. Furthermore, loss of one of Klf5 alleles reduced levels of K-Ras effector proteins and prevented mortality of Villin-Cre/LSL-K-RasG12D mice upon AOM treatment. The Villin-Cre/LSL-K-RasG12D mice spontaneously develop hyperplastic intestinal polyps and display a hyper-proliferative intestinal phenotype with elongated crypts, increased numbers of mitotic figures, elevated expression of KLF5, and other pro-proliferative targets. Induction of colonic tumorigenesis with AOM is detrimental to Villin-Cre/LSL-K-RasG12D mice that is in part dependent of KLF5.

Entities:  

Keywords:  KLF5; KRAS; colonic tumorigenesis; intestinal hyper-proliferation

Year:  2018        PMID: 29736317      PMCID: PMC5934562     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  22 in total

1.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.

Authors:  David A Tuveson; Alice T Shaw; Nicholas A Willis; Daniel P Silver; Erica L Jackson; Sandy Chang; Kim L Mercer; Rebecca Grochow; Hanno Hock; Denise Crowley; Sunil R Hingorani; Tal Zaks; Catrina King; Michael A Jacobetz; Lifu Wang; Roderick T Bronson; Stuart H Orkin; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

Review 2.  The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology.

Authors:  Beth B McConnell; Amr M Ghaleb; Mandayam O Nandan; Vincent W Yang
Journal:  Bioessays       Date:  2007-06       Impact factor: 4.345

3.  Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.

Authors:  Ying Feng; Guido T Bommer; Jenny Zhao; Maranne Green; Evan Sands; Yali Zhai; Kelly Brown; Aaron Burberry; Kathleen R Cho; Eric R Fearon
Journal:  Gastroenterology       Date:  2011-05-18       Impact factor: 22.682

4.  Krüppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells.

Authors:  Yizeng Yang; Bree G Goldstein; Hiroshi Nakagawa; Jonathan P Katz
Journal:  FASEB J       Date:  2006-12-08       Impact factor: 5.191

5.  Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.

Authors:  Mandayam O Nandan; Sengthong Chanchevalap; W Brian Dalton; Vincent W Yang
Journal:  FEBS Lett       Date:  2005-08-29       Impact factor: 4.124

Review 6.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

7.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.

Authors:  Patty Trobridge; Sue Knoblaugh; M Kay Washington; Nina M Munoz; Karen D Tsuchiya; Andres Rojas; Xiaoling Song; Cornelia M Ulrich; Takehiko Sasazuki; Senji Shirasawa; William M Grady
Journal:  Gastroenterology       Date:  2009-02-04       Impact factor: 22.682

8.  Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine.

Authors:  Beth B McConnell; Agnieszka B Bialkowska; Mandayam O Nandan; Amr M Ghaleb; Frank J Gordon; Vincent W Yang
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis.

Authors:  Mandayam O Nandan; Beth B McConnell; Amr M Ghaleb; Agnieszka B Bialkowska; Hongmiao Sheng; Jinyi Shao; Brian A Babbin; Sylvie Robine; Vincent W Yang
Journal:  Gastroenterology       Date:  2007-10-17       Impact factor: 22.682

10.  Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.

Authors:  Owen J Sansom; Valerie Meniel; Julie A Wilkins; Alicia M Cole; Karin A Oien; Victoria Marsh; Thomas J Jamieson; Carmen Guerra; Gabrielle H Ashton; Mariano Barbacid; Alan R Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

View more
  3 in total

1.  The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer In Vitro and In Vivo.

Authors:  Julie Kim; Chao Wang; Ainara Ruiz de Sabando; Hannah L Cole; Timothy J Huang; Jie Yang; Thomas D Bannister; Vincent W Yang; Agnieszka B Bialkowska
Journal:  Mol Cancer Ther       Date:  2019-07-29       Impact factor: 6.261

2.  Constitutive activation of mitogen-activated protein kinase kinase (MEK1) in ileal enterocytes leads to dysplasia and a predisposition to cancer.

Authors:  Benjamin L Shneider; Nahir Cortes-Santiago; Deborah A Schady; Swapna Krishnamoorthy; Sundararajah Thevananther; Kimal Rajapakshe; Dimuthu Perera; Shixia Huang; Cristian Coarfa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-20       Impact factor: 4.052

3.  SMDB: pivotal somatic sequence alterations reprogramming regulatory cascades.

Authors:  Limin Jiang; Mingrui Duan; Fei Guo; Jijun Tang; Olufunmilola Oybamiji; Hui Yu; Scott Ness; Ying-Yong Zhao; Peng Mao; Yan Guo
Journal:  NAR Cancer       Date:  2020-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.